SPDR® S&P Pharmaceuticals ETF (XPH US) stock market data APIs
54.9055
0.62(1.1%)
as of March 5, 2026
Try our APIs with
free plan!
SPDR® S&P Pharmaceuticals ETF Financial Data Overview
Price chart is built with
Anychart
Prev. Close
54.9055
Open
55.5229
High
56.252
Low
54.5164
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get SPDR® S&P Pharmaceuticals ETF data using free add-ons & libraries
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SPDR® S&P Pharmaceuticals ETF News
New
XPH’s 29% Run Looks Tempting, But The 5y Chart Is A Warning
Quick Read SPDR S&P Pharmaceuticals ETF (XPH) returned 29.44% over one year versus the S&P 500’s 12%. XPH gained only 10.49% over five years while the broader market returned 74.77%. XPH’s equal ...
Most and least shorted healthcare stocks with up to $2B market cap
Short interest in small-cap healthcare surged toward the end of January, centering heavily on the biotechnology sector. Data as of January 30 shows that KalVista (KALV [https://seekingalpha.com/symbol...
The top-performing pharma and biotech stocks as group sees resurgence
[Young female scientist working in laboratory] Solskin Pharmaceutical (PJP [https://seekingalpha.com/symbol/PJP]), (XPH [https://seekingalpha.com/symbol/XPH]), (PPH [https://seekingalpha.com/symbol/P...
10 surprises for 2026 according to UBS, where consensus could be wrong
[Data particle around the Earth which with stock charts in cyber space] Hiroshi Watanabe UBS’s global equity strategy team published a list of 10 ideas challenging consensus views and identifying w...
Get SPDR® S&P Pharmaceuticals ETF fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
